Advances in Neurodegenerative Disease Therapy: Stem Cell Clinical Trials and Promise of Engineered Exosomes
CNS Neuroscience & Therapeutics · 2025-09 · 31 (9)
DOI: 10.1111/cns.70577 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 04.09.2025. Verfasst von Sevim Isik und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Uskudar University, Uskudar, Istanbul, Turkey. Hauptthemen laut MEDLINE: Exosomes, Neurodegenerative Diseases, Stem Cell Transplantation, Clinical Trials as Topic. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aim
This review provides a systematic evaluation of 94 stem cell clinical trials to treat neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and Huntington's disease.
Methods
Data were collected from using relevant search terms, focusing exclusively on stem cell therapy. Of the 8000+ participants in these trials, nearly 70% were enrolled in AD‐related studies. Only three Phase 3 studies were conducted, and most trials were in the early phases (Phases 1 and 2). Mesenchymal stem cells, neural stem cells, induced pluripotent stem cells, and embryonic stem cells are used the most to treat neurodegenerative diseases. This review also explores the emerging fields of preclinical and clinical investigations of stem cell‐derived exosome‐based therapies for neurodegenerative diseases.
Results
Exosomes can cross the blood–brain barrier to deliver therapeutic molecules directly to the brain, offering a less invasive alternative to stem cell transplantation. Mesenchymal stem cell‐derived exosomes, in particular, have demonstrated significant potential in preclinical models by reducing neuroinflammation, oxidative stress, and promoting neuronal regeneration. Additionally, recent advances in exosome engineering, including surface modifications, therapeutic agent loading, and transgenic modifications, have improved targeting, stability, blood–brain barrier delivery, and neural cell interactions, enabling targeted and effective treatment. Exosome‐based therapies are in the preliminary phases of clinical investigation, with only three clinical trials.
Conclusion
Given the increasing interest in exosome therapy, clinical investigations are expected to increase. This growth will be driven by ongoing advancements in exosome technology, a deeper understanding of their therapeutic potential, and escalating demand for innovative treatment strategies for neurodegenerative diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Uskudar University, Uskudar, Istanbul, Turkey.
- Stem Cell Research and Application Center (USKOKMER), Uskudar University, Uskudar, Istanbul, Turkey.
- NPCELLAB Cellular Therapy, Stem Cell and Advanced Therapy Medicinal Products GMP Laboratory, Uskudar University, Uskudar, Istanbul, Turkey.
- Department of Molecular Biology, Institute of Science, Uskudar University, Uskudar, Istanbul, Turkey.
ORCID-Profile: Sevim Isik, Sajeda Osman, Bercem Yeman-Kiyak, Suhair Rami Mohammed Shamshir
Zitieren
APA
Isik, S., Osman, S., Yeman-Kiyak, B., Shamshir, S. R. M., & Sanchez, N. M. E. (2025). Advances in Neurodegenerative Disease Therapy: Stem Cell Clinical Trials and Promise of Engineered Exosomes. CNS Neuroscience & Therapeutics, 31(9). https://doi.org/10.1111/cns.70577
Vancouver
Isik S, Osman S, Yeman-Kiyak B, Shamshir SRM, Sanchez NME. Advances in Neurodegenerative Disease Therapy: Stem Cell Clinical Trials and Promise of Engineered Exosomes. CNS Neuroscience & Therapeutics. 2025;31(9). doi:10.1111/cns.70577
BibTeX
@article{Isik2025,
author = {Isik, Sevim and Osman, Sajeda and Yeman-Kiyak, Bercem and Shamshir, Suhair Rami Mohammed and Sanchez, Nesrin Majdi Edwan},
title = {Advances in Neurodegenerative Disease Therapy: Stem Cell Clinical Trials and Promise of Engineered Exosomes},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
volume = {31},
number = {9},
doi = {10.1111/cns.70577}
}
EUVIMED